478 related articles for article (PubMed ID: 25393244)
1. Clinical features and patient management of Lujo hemorrhagic fever.
Sewlall NH; Richards G; Duse A; Swanepoel R; Paweska J; Blumberg L; Dinh TH; Bausch D
PLoS Negl Trop Dis; 2014; 8(11):e3233. PubMed ID: 25393244
[TBL] [Abstract][Full Text] [Related]
2. Delayed inflammatory and cell death responses are associated with reduced pathogenicity in Lujo virus-infected cynomolgus macaques.
Rasmussen AL; Tchitchek N; Safronetz D; Carter VS; Williams CM; Haddock E; Korth MJ; Feldmann H; Katze MG
J Virol; 2015 Mar; 89(5):2543-52. PubMed ID: 25520505
[TBL] [Abstract][Full Text] [Related]
3. [Lujo hemorrhagic fever].
Sizikova TE; Lebedev VN; Syromyatnikova SI; Borisevich SV
Vopr Virusol; 2017; 62(4):149-153. PubMed ID: 29733163
[TBL] [Abstract][Full Text] [Related]
4. Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks.
Simulundu E; Mweene AS; Changula K; Monze M; Chizema E; Mwaba P; Takada A; Ippolito G; Kasolo F; Zumla A; Bates M
Rev Med Virol; 2016 Nov; 26(6):446-454. PubMed ID: 27593704
[TBL] [Abstract][Full Text] [Related]
5. Rapid molecular detection of Lujo virus RNA.
Atkinson B; Chamberlain J; Dowall SD; Cook N; Bruce C; Hewson R
J Virol Methods; 2014 Jan; 195():170-3. PubMed ID: 24096270
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial outbreak of novel arenavirus infection, southern Africa.
Paweska JT; Sewlall NH; Ksiazek TG; Blumberg LH; Hale MJ; Lipkin WI; Weyer J; Nichol ST; Rollin PE; McMullan LK; Paddock CD; Briese T; Mnyaluza J; Dinh TH; Mukonka V; Ching P; Duse A; Richards G; de Jong G; Cohen C; Ikalafeng B; Mugero C; Asomugha C; Malotle MM; Nteo DM; Misiani E; Swanepoel R; Zaki SR;
Emerg Infect Dis; 2009 Oct; 15(10):1598-602. PubMed ID: 19861052
[TBL] [Abstract][Full Text] [Related]
7. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
Kerber R; Reindl S; Romanowski V; Gómez RM; Ogbaini-Emovon E; Günther S; ter Meulen J
J Clin Virol; 2015 Mar; 64():120-7. PubMed ID: 25549822
[TBL] [Abstract][Full Text] [Related]
8. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
[TBL] [Abstract][Full Text] [Related]
9. Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus.
Bird BH; Dodd KA; Erickson BR; Albariño CG; Chakrabarti AK; McMullan LK; Bergeron E; Ströeher U; Cannon D; Martin B; Coleman-McCray JD; Nichol ST; Spiropoulou CF
PLoS Negl Trop Dis; 2012; 6(8):e1801. PubMed ID: 22953019
[TBL] [Abstract][Full Text] [Related]
10. Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.
Brisse ME; Ly H
Front Immunol; 2019; 10():372. PubMed ID: 30918506
[TBL] [Abstract][Full Text] [Related]
11. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
[TBL] [Abstract][Full Text] [Related]
12. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
Kunz S
Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of arenavirus hemorrhagic fevers.
Moraz ML; Kunz S
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):49-59. PubMed ID: 21171877
[TBL] [Abstract][Full Text] [Related]
14. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
Gowen BB; Smee DF; Wong MH; Hall JO; Jung KH; Bailey KW; Stevens JR; Furuta Y; Morrey JD
PLoS One; 2008; 3(11):e3725. PubMed ID: 19008960
[TBL] [Abstract][Full Text] [Related]
15. Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.
Colebunders R; Van Esbroeck M; Moreau M; Borchert M
Acta Clin Belg; 2002; 57(5):233-40. PubMed ID: 12534129
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic fever viruses as biological weapons: medical and public health management.
Borio L; Inglesby T; Peters CJ; Schmaljohn AL; Hughes JM; Jahrling PB; Ksiazek T; Johnson KM; Meyerhoff A; O'Toole T; Ascher MS; Bartlett J; Breman JG; Eitzen EM; Hamburg M; Hauer J; Henderson DA; Johnson RT; Kwik G; Layton M; Lillibridge S; Nabel GJ; Osterholm MT; Perl TM; Russell P; Tonat K;
JAMA; 2002 May; 287(18):2391-405. PubMed ID: 11988060
[TBL] [Abstract][Full Text] [Related]
17. [Arenavirus research and antiviral candidate].
Tani H; Shuzo U
Uirusu; 2018; 68(1):51-62. PubMed ID: 31105135
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
de la Torre JC
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of clinical and laboratory data in two cases of imported Lassa fever.
Schmitz H; Köhler B; Laue T; Drosten C; Veldkamp PJ; Günther S; Emmerich P; Geisen HP; Fleischer K; Beersma MF; Hoerauf A
Microbes Infect; 2002 Jan; 4(1):43-50. PubMed ID: 11825774
[TBL] [Abstract][Full Text] [Related]
20. Report of a fatal case of Lassa fever in Parakou in 2018: clinical, therapeutic and diagnostic aspects.
Attinsounon CA; Ossibi Ibara BR; Alassani A; Adé S; Saké K; Glèlè Kakaï C; Dovonou A
BMC Infect Dis; 2018 Dec; 18(1):667. PubMed ID: 30558538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
